Saying that a lack of management testimony on key plan issues was "fatal," a Delaware bankruptcy judge on Friday rejected a Chapter 11 plan offered by biopharmaceutical venture Vivus Inc. and ordered the addition of a stockholder committee to the company's future plan-drafting efforts.